NDC 84066-109 – Medultima Adventure Sunscreen
Octocrylene 7 g/100g; Ethylhexyl Salicylate 4 g/100g; Phenylbenzimidazole Sulfonic Acid 4 g/100g; Butyl Methoxydibenzoylmethane 3 g/100g; Homosalate 9 g/100g · Cream · Topical
Product NDC84066-109
Product details
- Brand name
- Medultima Adventure Sunscreen
- Generic name
- Homosalate,Octocrylene, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane
- Labeler
- Guangzhou Tata Biotechnology Co., Ltd.
- Dosage form
- Cream
- Route
- Topical
- Marketing category
- OTC MONOGRAPH DRUG · M020
- Marketed since
- June 4, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Octocrylene 7 g/100g
- Ethylhexyl Salicylate 4 g/100g
- Phenylbenzimidazole Sulfonic Acid 4 g/100g
- Butyl Methoxydibenzoylmethane 3 g/100g
- Homosalate 9 g/100g
Uses, dosage, side effects and warnings for Medultima Adventure Sunscreen →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 84066-109-01 | 50 g in 1 BOTTLE (84066-109-01) | Jun 4, 2026 |